Novo Nordisk A/S(NVO)
NASDAQ

Stock Price Forecast & Analyst Targets

$47.51
0.74 (1.58%)

NVO Stock Forecast Chart

NVO Stock Forecast 2026 – Price Prediction, Target & Outlook

Novo Nordisk A/S (NVO) stock forecast for 2026 indicates a wide range of potential outcomes based on analyst targets and model-driven predictions. As of September 2026, NVO stock shows a dynamic price pattern in the short term, with price targets reflecting potential future volatility across bull, base, and bear scenarios over the next 12 months.

NVO Bull Case Price Target (2027)

$87.36

In a bullish scenario, NVO stock could reach this maximum projection over the next 12 months, driven by upside momentum and outperforming technical indicators.

NVO Base Forecast (2027)

$69.07

The base case model predicts this median target, assuming NVO maintains steady growth, consistent volume profiles, and normalized market conditions.

NVO Bear Case Price Target (2027)

$50.77

In a broader market downturn or bearish correction, NVO shares could potentially trace back to this support level over the forecast horizon.

Confidence:60.8% (Moderate)
Signal:Short-Term Bearish
6M + 12M
Historical
Forecast Avg
Max Range
Min Range
Prophet Model Forecast

Novo Nordisk A/S Analyst Consensus & Target Price

Wall Street sentiment and price target analysis for NVO

HOLD

Consensus based on 12 analysts

Neutral outlook - price at fair value

Mean Target Price
$47.17-0.7%
High Target$64.07
Low Target$40.21
Number of Opinions12

Price Target Analysis

Target Range: $40.21 - $64.07

Current vs Mean Target: -0.7%

Analyst Coverage: 12 firms tracking

Key Considerations

• Target prices reflect 12-month outlook

• Based on fundamental analysis and DCF models

• Consider market volatility in timing decisions

NVO stock Price Projections & Forecast Models

Data-driven price predictions based on technical analysis and analyst consensus for NVO

Model-Based Predictions

$49.31
1-Month Target
+3.8%
$69.07
1-Year Target
+45.4%

Analyst Consensus

$47.17
Analyst Mean Target
-0.7% vs Current

Model Methodology & Confidence

Technical Indicators:

  • • Moving averages (SMA 20, 50, 200)
  • • RSI and momentum oscillators
  • • Support/resistance levels
  • • Volume-price analysis

Fundamental Factors:

  • • Earnings growth projections
  • • Revenue trend analysis
  • • Valuation multiple normalization
  • • Sector performance correlation

Scenario Analysis Chart

Novo Nordisk A/S (NVO) Detailed Price Forecast

Algorithmic projections for monthly price bands and momentum signals

According to current predictive modeling and historical volatility analysis, the company is projected to fluctuate between a potential low of $45.54 and a high of $87.36 over the forecast horizon. These estimates blend near-term technical momentum with fundamental analyst consensus targets.

PeriodMin PriceAvg PriceMax PricePotential ROISignal
Oct 202645.5449.3153.08+3.8%
Hold
Nov 202645.5851.1056.63+7.6%
Buy
Dec 202645.8952.9059.90+11.3%
Buy
Jan 202746.3354.7063.06+15.1%
Buy
Feb 202746.8356.4966.15+18.9%
Buy
Mar 202747.3758.2969.20+22.7%
Buy
Apr 202747.9360.0872.24+26.5%
Buy
May 202748.5061.8875.26+30.2%
Buy
Jun 202749.0763.6878.28+34.0%
Buy
Jul 202749.6465.4781.30+37.8%
Buy
Aug 202750.2167.2784.33+41.6%
Buy
Sep 202750.7769.0787.36+45.4%
Buy

Source methodology: Model forecasts are independent estimates blending technical signals with analyst consensus data. Actual market prices are subject to volatility and macroeconomic factors. All projections are for informational purposes only.